lenalidomide has been researched along with ps1145 in 2 studies
| Studies (lenalidomide) | Trials (lenalidomide) | Recent Studies (post-2010) (lenalidomide) | Studies (ps1145) | Trials (ps1145) | Recent Studies (post-2010) (ps1145) |
|---|---|---|---|---|---|
| 3,532 | 725 | 2,850 | 54 | 1 | 25 |
| Protein | Taxonomy | lenalidomide (IC50) | ps1145 (IC50) |
|---|---|---|---|
| Inhibitor of nuclear factor kappa-B kinase subunit beta | Homo sapiens (human) | 0.1646 | |
| Inhibitor of nuclear factor kappa-B kinase subunit alpha | Homo sapiens (human) | 0.1 | |
| Serine/threonine-protein kinase pim-1 | Homo sapiens (human) | 1.1 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.1 | |
| Serine/threonine-protein kinase pim-3 | Homo sapiens (human) | 0.88 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
| Anderson, KC | 1 |
2 other study(ies) available for lenalidomide and ps1145
| Article | Year |
|---|---|
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
Moving disease biology from the lab to the clinic.
Topics: Bone Marrow; Boronic Acids; Bortezomib; Cell Division; Drug Delivery Systems; Heterocyclic Compounds, 3-Ring; Humans; Lenalidomide; Models, Biological; Multiple Myeloma; Protease Inhibitors; Pyrazines; Pyridines; Thalidomide | 2003 |